Mycoplasma pneumoniae cytadhesin P1 was purified by monoclonal antibody affinity chromatography followed by preparative sodium dodecyl sulfate-polyacrylamide gel electrophoresis. The N-terminal 18-aminoacid sequence of P1 was determined and used to design two synthetic oligonucleotides, a 14-mer corresponding to amino acids 1 to 5 and an 18-mer corresponding to amino acids 7 to 12. These oligonucleotides served as hybridization probes for the identification of the P1 gene by Southern blot analysis ofM. pneumoniae DNA. The P1 gene was cloned into plasmid pUC19 and mapped by using appropriate restriction endonucleases. The DNA sequence of the entire P1 gene was determined by subcloning appropriate DNA fragments into bacteriophage M13 and sequencing the DNA by the dideoxy-chain-termination method. The P1 gene contains an open reading frame of 4,881 nucleotides coding for a protein of 1,627 amino acids with a calculated molecular weight of 176,288. Properties of the amino-terminal sequence suggest that protein P1 may be synthesized as a precursor with subsequent processing to a mature protein of a calculated molecular weight of 169,758. Potential antigenic sites were determined by hydrophilicity plots. A computer search revealed that part of the predicted P1 sequence is homologous to cytoskeletal keratin of mammalian species and human fibrinogen alpha chain precursor. These results demonstrate the uniqueness of P1 as a cytadhesin and virulence determinant.
Mycoplasma-mediated human disease represents a major class of infections which are poorly understood. Mycoplasma pneumoniae, the etiological agent of primary atypical pneumonia, possesses a tiplike organelle which permits a highly oriented extracellular parasitism of the respiratory epithelium (5, 11, 26) . A surface-localized, trypsin-sensitive protein designated P1 (165 kilodaltons [kDa] ) clusters at the mycoplasma terminus and is essential for the cytadherence event (1, 2, 6, 10) . Mutants of M. pneumoniae which lack P1 or are unable to mobilize and anchor P1 at the tip are avirulent (1, 15, 16) . Also, trypsin treatment of wild-type virulent mycoplasmas abrogates the functionality of P1 as an adhesin (1, 2, 10, 11, 23) . Thus, it is well established that P1 is a critical virulence determinant but efforts to define structural-functional domains of this hydrophobic, integral membrane protein have failed.
Our previous attempts to clone the P1 gene by introducing recombinant molecules containing M. pneumoniae DNA into E. coli and screening immunologically for the expression of protein P1 were of limited success (31) . This may be due to the premature termination of M. pneumoniae proteins in Escherichia coli since Yamao et al. (35) recently reported that in Mycoplasma capricolum TGA encodes tryptophan rather than a termination signal.
In this report we describe the cloning of the P1 gene using an approach which does not require expression of the P1 protein in E. coli. We also present the DNA sequence of the P1 gene and the deduced sequence of the P1 protein.
MATERIALS AND METHODS
Organisms and growth conditions. Virulent hemadsorbing M. pneumoniae M129 in the 16th broth passage was grown at 37°C in 32-oz. (ca. 946-ml) glass prescription bottles containing 70 ml of Edward medium as previously described (23) . (3) . For use as hybridization probes, the oligonucleotides were labeled at the 5' end with [-y-32P]ATP by the T4-polynucleotide kinase reaction (20) .
Southern blot analysis of M. pneumoniae DNA. M. pneumoniae DNA was prepared from exponentially growing cells as previously described (31) . DNA (12 gig) was (20) . Mycoplasma DNA and vector were mixed at 1:1 molar ratios and ligated at room temperature for 4 h with T4 DNA ligase (20) . After incubation the reaction was stopped by adding EDTA to 10 mM and diluted fivefold with distilled H20, and the DNA was used to transform competent HB101 or DH5at E. coli cells according to the instructions of the manufacturer (Bethesda Research Laboratories, Inc., Gaithersburg, Md.). Transformants were selected on LB agar plates containing 50 ,ug of ampicillin per ml. Individual colonies were picked and grown overnight in 5 ml of LB broth containing 50 jig of ampicillin per ml.
Plasmid DNA was isolated from overnight cultures by the alkaline lysis method (13) and analyzed on agarose gels. To determine which insert-containing plasmids carried the P1 gene, plasmid DNAs were blotted onto nitrocellulose filters. The filters were then hybridized to the 32P-labeled 18-mer oligonucleotide probes, washed, and exposed to film as described above.
DNA sequencing. DNA sequences were determined by the dideoxy-chain-termination method of Sanger et al. (29) . M13 sequencing kits were purchased from Bethesda Research Laboratories, and the reactions were performed according to the instructions of the manufacturer, except that deoxy-7-deaza GTP (Boehringer Mannheim Biochemicals, Indianapolis, Ind.) was used in sequencing reactions in place of dGTP (22) . Some DNA fragments were sequenced by subcloning appropriate restriction enzyme fragments into an M13 bacteriophage vector (21) , and the single-stranded DNA was purified for use as a sequencing template. To (Fig. 1A to C) . Approximately 400 gig of P1 protein was recovered after the immunoaffinity step from an initial M. pneumoniae extract containing 300 mg of total protein. The affinity column-purified P1 was further processed by preparative gel electrophoresis through a 5% polyacrylamide-SDS gel, and the 165-kDa protein was recovered by electroelution. About 60% recovery was achieved after 24 h of elution at room temperature in 50 mM ammonium carbonate containing 0.1% SDS. The eluted protein was then precipitated in 80% methanol to remove SDS. SDS-PAGE analysis of the recovered P1 revealed that the sample contained intact P1 protein (Fig. ID) , and the gel was deliberately overloaded to show the purity of the sample. Finally, the purified protein was shown to be P1 since it reacted with anti-Pl monoclonal antibodies in Western blot analyses (data not shown).
Generation of oligonucleotide probes. The amino-terminal amino acid sequence of P1 protein was determined by gas phase microsequencing. Three separate determinations yielded the sequence shown in Fig. 2 . Two oligonucleotide probes complementary to all the possible mRNA combinations encoding different portions of the protein were synthesized, a 14-mer corresponding to amino acids 1 to 5 and an 18-mer corresponding to amino acids 7 to 12 (Fig. 2) . Because M. pneumnoniae may use TGA instead of TGG to encode tryptophan, both C and T were used in the third position of the tryptophan codon of the 18-bp oligonucleo- (Fig. 4 to 6 ) contains the appropriate P1 gene sequence not only because it hybridizes to both 14-mer and 18-mer probes, but also because it codes for all 18 amino acids determined from the N-terminal sequencing of the purified P1 protein. Of interest is the observation that the 10th amino acid that we sequenced from the N-terminus is a tryptophan, which further suggests that if E. coli uses the P1 promoter sequence, the protein might be terminated prematurely.
From the nucleotide sequences, a possible translational initiation site ATG occurs in frame, which is 177 nucleotides from the P1 N-terminal sequence. There are conventional transcription initiation sites at -35 and -10 upstream with a distance of 14 nucleotides between these two consensus sequences (27) , but no ribosome-binding site is observed between -10 and the initiation codon. This predicts a protein with an extension of 59 amino acids from the N terminus. Another possible translational initiation codon is the GTG (7) at position 91. Use of this initiation site would predict a 28-amino-acid precursor. Since all of the predictions are made on the basis of the study of E. coli and other procaryotic organisms and no information about mycoplasma promoter or initiation sites is available, further study is needed to determine the precise transcriptional and translational initiation sites.
The predicted P1 gene sequence is consistent with available information about protein P1: (i) the predicted molecular weight of P1 approximates the reported values; (ii) the predicted N-terminal amino acid sequence fits exactly with the gas phase sequence analysis of purified P1 protein; (iii) the predicted P1 sequence contains more basic amino acids (Arg + Lys + His = 169) than acidic (Asp + Glu = 143) (our unpublished isoelectric focusing data show that P1 has an isoelectric point at a basic pH); (iv) the predicted P1 has no intramolecular disulfide bonding, which correlates with our previous observation that the P1 position in polyacrylamide gels is not changed after exposure to sample buffer containing reducing agents.
Since cytadhesin P1 is strongly immunogenic based upon humoral immune response data in humans and hamsters (19) and the appearance of anti-Pl antibodies correlates with resolution of the infection (19) , we are interested in identifying the antigenic sites which may serve as effective vaccine candidates. The hydrophilicity plot (Fig. 7) implicates several potential sites. It is fascinating that parts of the P1 sequence are homologous to specific viral coat proteins and mammalian cytoskeletal keratin as well as the human fibrinogen alpha chain precursor, which may relate to previous observations of autoimmune-like mechanisms of pathophysiology associated with mycoplasma disease (4, 33) . Now that the gene sequence of M. pneumoniae cytadhesin P1 has been delineated and its protein sequence has been deduced, we can begin to address other relevant issues. Do gene duplications or rearrangements of the P1 gene occur? Why does P1 lose functionality as an adhesin after brief protease treatment? What factors regulate the mobilization and clustering of P1 at the tip organelle, and what is the basis for the cooperative interactions between P1 and other membrane proteins (1, 17) ? Will synthetic peptides which substitute for the immunologically and functionally relevant domains of P1 serve as effective vaccine candidates and diagnostic probes? Can the available P1 gene and protein data assist in characterizing the immunologically related 140-kDa protein (23) of the newly discovered human pathogen, Mycoplasma genitalium (32)? In addition, identification of the host cell receptor(s) which mediates M. pneumoniae cytadherence in the respiratory tract has been elusive, and information provided by the Pl sequence may assist in defining tissue tropism at the molecular level.
